Cargando…

COVID-19 and Health Outcomes in People with Multiple Sclerosis: A Population-Based Study in Italy

People with multiple sclerosis (PWMS) are at high risk of being affected by the disruption of health services that occurred during the COVID-19 pandemic months. The aim of this study was to evaluate the effect of the pandemic on the health outcomes of PWMS. PWMS and MS-free residing in Piedmont (nor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gnavi, Roberto, Eboli, Ilenia, Alboini, Paolo Emilio, D’Alfonso, Sandra, Picariello, Roberta, Costa, Giuseppe, Leone, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223309/ https://www.ncbi.nlm.nih.gov/pubmed/37240734 http://dx.doi.org/10.3390/life13051089

Ejemplares similares

Determinants of Quality in Diabetes Care Process: The population-based Torino Study
por: Gnavi, Roberto, et al.
Publicado: (2009)

The Impact of Lifetime Alcohol and Cigarette Smoking Loads on Multiple Sclerosis Severity
por: Ivashynka, Andrei, et al.
Publicado: (2019)

The Impact of Adherence to Screening Guidelines and of Diabetes Clinics Referral on Morbidity and Mortality in Diabetes
por: Giorda, Carlo, et al.
Publicado: (2012)

From swab testing to health outcomes within the T2DM population: Impact of diabetes background on COVID19 progression
por: Giorda, Carlo Bruno, et al.
Publicado: (2021)

Hospitalisation for heart failure and mortality associated with dipeptidyl peptidase 4 (DPP-4) inhibitor use in an unselected population of subjects with type 2 diabetes: a nested case–control study
por: Giorda, Carlo B, et al.
Publicado: (2015)

A Scoping Review on Body Fluid Biomarkers for Prognosis and Disease Activity in Patients with Multiple Sclerosis
por: Barizzone, Nadia, et al.
Publicado: (2022)

HLA alleles modulate EBV viral load in multiple sclerosis
por: Agostini, Simone, et al.
Publicado: (2018)

Is the choice of the statistical model relevant in the cost estimation of patients with chronic diseases? An empirical approach by the Piedmont Diabetes Registry
por: Pagano, Eva, et al.
Publicado: (2015)

The Impact of Osteopontin Gene Variations on Multiple Sclerosis Development and Progression
por: Comi, Cristoforo, et al.
Publicado: (2012)

Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis
por: Gemmati, Donato, et al.
Publicado: (2012)

Monitoring adherence to pharmacological therapy and follow-up examinations among patients with type 2 diabetes in community pharmacies. Results from an experience in Italy
por: Spadea, Teresa, et al.
Publicado: (2021)

Instructive lessons from the analysis of assistance in diabetes during the first phase of COVID-19 pandemic
por: Giorda, Carlo B, et al.
Publicado: (2022)

Opportunistic screening for type 2 diabetes in community pharmacies. Results from a region-wide experience in Italy
por: Gnavi, Roberto, et al.
Publicado: (2020)

Contribution of Rare and Low-Frequency Variants to Multiple Sclerosis Susceptibility in the Italian Continental Population
por: Clarelli, Ferdinando, et al.
Publicado: (2022)

Socioeconomic and citizenship inequalities in hospitalisation of the adult population in Italy
por: Petrelli, Alessio, et al.
Publicado: (2020)

Infodemiology and Infoveillance of Multiple Sclerosis in Italy
por: Bragazzi, Nicola Luigi
Publicado: (2013)

Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy)
por: Bezzini, Daiana, et al.
Publicado: (2022)

Indirect impact of Covid-19 on hospital care pathways in Italy
por: Spadea, Teresa, et al.
Publicado: (2021)

The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study
por: D’Amico, Emanuele, et al.
Publicado: (2016)

Health status assessment of a population of asylum seekers in Northern Italy
por: Manfredi, Luca, et al.
Publicado: (2022)

Multiple Sclerosis in the Campania Region (South Italy): Algorithm Validation and 2015–2017 Prevalence
por: Moccia, Marcello, et al.
Publicado: (2020)

Self-medication for migraine: A nationwide cross-sectional study in Italy
por: Brusa, Paola, et al.
Publicado: (2019)

A seasonal periodicity in relapses of multiple sclerosis? A single-center, population-based, preliminary study conducted in Bologna, Italy
por: Salvi, Fabrizio, et al.
Publicado: (2010)

Microchimerism in multiple sclerosis: The association between sex of offspring and MRI features in women with multiple sclerosis
por: Bianchi, Alessia, et al.
Publicado: (2023)

Decision-Making in Multiple Sclerosis Consultations in Italy: Third Observer and Patient Assessments
por: Pietrolongo, Erika, et al.
Publicado: (2013)

Cycling for a Sustainable Touristic Mobility: A Preliminary Study in an Urban Area of Italy
por: Mazzulla, Gabriella, et al.
Publicado: (2021)

Assessment of Non-Adherence to Oral Metformin and Atorvastatin Therapies: A Cross-Sectional Survey in Piedmont (Italy)
por: Parente, Marco, et al.
Publicado: (2020)

The Epidemiology, Treatment Patterns and Economic Burden of Different Phenotypes of Multiple Sclerosis in Italy: Relapsing-Remitting Multiple Sclerosis and Secondary Progressive Multiple Sclerosis
por: Perrone, Valentina, et al.
Publicado: (2022)

Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients
por: Leone, Maurizio A., et al.
Publicado: (2013)

HLA-class I markers and multiple sclerosis susceptibility in the Italian population
por: Bergamaschi, L, et al.
Publicado: (2009)

Defining routine fatigue care in Multiple Sclerosis in the United Kingdom: What treatments are offered and who gets them?
por: Picariello, Federica, et al.
Publicado: (2022)

Vaccine response in people with multiple sclerosis treated with fumarates
por: Tremblay, Matthew A., et al.
Publicado: (2023)

Unmet care needs of people with a neurological chronic disease: a cross-sectional study in Italy on Multiple Sclerosis
por: Ponzio, Michela, et al.
Publicado: (2015)

Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy
por: Giossi, Riccardo, et al.
Publicado: (2022)

Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy
por: Cortesi, Paolo Angelo, et al.
Publicado: (2022)

Vaccine hesitancy in people with multiple sclerosis
por: Lechner-Scott, Jeannette S, et al.
Publicado: (2022)

Medication discrepancies across multiple care transitions: A retrospective longitudinal cohort study in Italy
por: Bonaudo, Marco, et al.
Publicado: (2018)

Occupational outcomes of people with multiple sclerosis: a scoping review
por: Vitturi, Bruno Kusznir, et al.
Publicado: (2022)

Conversion to secondary progressive multiple sclerosis: Multistakeholder experiences and needs in Italy
por: Giovannetti, Ambra Mara, et al.
Publicado: (2020)

Multiple sclerosis epidemiological trends in Italy highlight the environmental risk factors
por: Puthenparampil, M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_na0vnp3kc11n4r2ob2155qme0h